Kopran Pharmaceuticals Pvt Ltd - Charges

Every charge - open or closed - that lenders have registered against Kopran Pharmaceuticals Pvt Ltd, with the most recent activity at the to…

1983-12-24 Mumbai, Maharashtra Active Unlisted Active Non-Compliant
Share
KP Kopran Pharmaceuticals Pvt Ltd
Open charges
4
18.00 cr
Closed charges
0
0.00
Total
4
18.00 cr
Open vs closed
Top charge holders (by amount)
Top lenders
#LenderChargesAmount
1 Canara Bank 2 16.00 cr
2 The Kapol Co-Op. Bank Ltd. 2 2.00 cr
All charges (4) - latest first
Charge ID Charge holder Created Modified Satisfied Amount Status
90214900 Canara Bank 20 Jul 2002 31 Jul 2003 - 8.00 cr Open
90215764 Canara Bank 20 Jul 2002 26 Dec 2002 - 8.00 cr Open
90213398 The Kapol Co-Op. Bank Ltd. 10 Aug 1999 - - 1.00 cr Open
90215648 The Kapol Co-Op. Bank Ltd. 10 Aug 1999 - - 1.00 cr Open
Frequently Asked Questions - Charges & borrowings
What do "charges" mean for Kopran Pharmaceuticals Pvt Ltd?
Charges are registrable security interests-typically loans or credit facilities-filed with MCA against Kopran Pharmaceuticals Pvt Ltd (CIN: U24279MH1983PTC031653). They indicate assets or undertakings pledged to lenders or charge holders.
What is the difference between open and closed charges?
Open charges are active or not yet fully discharged; closed (or satisfied) charges are recorded as settled or released. Counts and amounts on this page follow the statuses shown in the charge list.
How should I read the open vs closed amounts?
Open and closed amounts summarise registrable amounts by status for quick comparison; individual rows may show charge-specific amounts, holders, and dates for verification.
Who are the "top lenders" or charge holders?
Top lenders group charge holders by bank or institution name and approximate exposure so you can see which lenders appear most prominently for Kopran Pharmaceuticals Pvt Ltd.
Where can I cross-check financial or ownership context?
Pair this Charges view with the Financial and Ownership sections on this company's V1 profile for loans in financial statements and cap table context alongside MCA charge filings.